日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy

利用间皮素靶向抗体构建体进行靶向CD47检查点阻断,以增强实体瘤特异性免疫治疗

Reischer, Anna; Leutbecher, Alexandra; Hiller, Björn; Perini, Enrico; White, Kieron; Hernández-Cáceres, Alejandra; Schele, Alexandra; Tast, Benjamin; Rohrbacher, Lisa; Winter, Lis; Czogalla, Bastian; Mahner, Sven; Flaswinkel, Heinrich; Leonhardt, Heinrich; Wyder, Lorenza; Wichmann, Christian; Maenner, Denis; Trillsch, Fabian; Kessler, Mirjana; Hopfner, Karl-Peter; Fenn, Nadja C; Subklewe, Marion

SIRPα-antibody fusion proteins stimulate phagocytosis and promote elimination of acute myeloid leukemia cells

SIRPα-抗体融合蛋白可刺激吞噬作用并促进急性髓系白血病细胞的清除。

Ponce, Laia Pascual; Fenn, Nadja C; Moritz, Nadine; Krupka, Christina; Kozik, Jan-Hendrik; Lauber, Kirsten; Subklewe, Marion; Hopfner, Karl-Peter

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.

CD19 特异性三体 SPM-1 可激活 NK 细胞和 α1T 细胞,从而快速有效地裂解恶性 B 淋巴细胞

Schiller Christian B, Braciak Todd A, Fenn Nadja C, Seidel Ursula J E, Roskopf Claudia C, Wildenhain Sarah, Honegger Annemarie, Schubert Ingo A, Schele Alexandra, Lämmermann Kerstin, Fey Georg H, Jacob Uwe, Lang Peter, Hopfner Karl-Peter, Oduncu Fuat S